Clinical trial
Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan
NCT05248919 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan
- Lead sponsor
- Queen Mary University of London
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- June 1, 2023
- Completion date
- September 30, 2027
- Enrollment
- 318 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.